CB
64
6
CINF
60
3
ALLE
50
9
DG
74
4
BIIB
48
-3
CAG
43
2
AIG
74
5
CME
48
6
SO
46
2
BRK.B
40
4
CTAS
40
6
BAX
48
4
ADM
50
6
CVX
28
-12
CA
24
-3
AEE
48
-2
D
35
-2
ACN
52
-2
BBY
48
2
CF
48
6
CB
64
6
CINF
60
3
ALLE
50
9
DG
74
4
BIIB
48
-3
CAG
43
2
AIG
74
5
CME
48
6
SO
46
2
BRK.B
40
4
CTAS
40
6
BAX
48
4
ADM
50
6
CVX
28
-12
CA
24
-3
AEE
48
-2
D
35
-2
ACN
52
-2
BBY
48
2
CF
48
6
Financhill
Back

Linamar Corp. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
46

LNR.TO
Linamar Corp.

Last Price:
$81.25
Seasonality Move:
4.39%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$87.93
Seasonality Move:
10.35%
Sell
46
Linamar Corp. (LNR.TO) is a Sell

Is Linamar Corp. a Buy, Sell or Hold?

  • The current Linamar Corp. [LNR.TO] share price is $81.25. The Score for LNR.TO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • LNR.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

LNR.TO Stock Price Chart

What is Linamar Corp.'s stock price today?

  • The Linamar Corp. share price today is $81.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LNR.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

LNR.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 63.21 Buy
Chaikin Money Flow: 92426 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.21 - 80.01) Buy
Bollinger Bands (100): (71.12 - 78.16) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

LNR.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.59 Buy
20-day SMA: 78.7 Buy
50-day SMA: 76.12 Buy
200-day SMA: 65.89 Buy
8-day EMA: 79.1 Buy
20-day EMA: 78.35 Buy
50-day EMA: 76.72 Buy
200-day EMA: 69.54 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Linamar Corp. Earnings Growth & LNR.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $1.35 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Linamar Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):